R
Radiopharm Theranostics Ltd
NASDAQ:RADX
Radiopharm Theranostics Ltd
NASDAQ:RADX
Price:
1.65
USD
2.48%
Market Closed
Market Cap:
$3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Radiopharm Theranostics Ltd
NASDAQ:RADX
|
AU |
|
P
|
Panoro Energy ASA
OSE:PEN
|
NO |
|
I
|
iStreet Network Ltd
BSE:524622
|
IN |
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
IT |
|
T
|
Target Corp
F:DYH
|
US |
|
M
|
MITCON Consultancy & Engineering Services Ltd
NSE:MITCON
|
IN |
|
S
|
Sixt SE
XMUN:SIX2
|
DE |
|
Y
|
Yeong Guan Energy Technology Group Co Ltd
TWSE:1589
|
CN |
|
Renaissance Inc
TSE:2378
|
JP |
|
B
|
Boutique Newcity PCL
SET:BTNC
|
TH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RADX's stock price target?
Price Target
13.46
USD
13.46
USD
According to Wall Street analysts, the average 1-year price target for RADX is 13.46 USD with a low forecast of 13.33 USD and a high forecast of 13.86 USD.
What is the Revenue forecast for Radiopharm Theranostics Ltd?
Projected CAGR
93%
93%
The compound annual growth rate for Revenue over the next 8 years is 93%.
What is the Gross Profit forecast for Radiopharm Theranostics Ltd?
Projected CAGR
234%
234%
The compound annual growth rate for Gross Profit over the next 8 years is 234%.